Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

MDxHealth (MDXH) EBIT Margin (2021 - 2025)

Historic EBIT Margin for MDxHealth (MDXH) over the last 5 years, with Q3 2025 value amounting to 139.95%.

  • MDxHealth's EBIT Margin fell 86200.0% to 139.95% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.23%, marking a year-over-year decrease of 1544300.0%. This contributed to the annual value of 21.9% for FY2024, which is 170300.0% up from last year.
  • Per MDxHealth's latest filing, its EBIT Margin stood at 139.95% for Q3 2025, which was down 86200.0% from 0.06% recorded in Q2 2025.
  • MDxHealth's 5-year EBIT Margin high stood at 221.72% for Q1 2022, and its period low was 152.02% during Q2 2022.
  • Over the past 5 years, MDxHealth's median EBIT Margin value was 153.32% (recorded in 2023), while the average stood at 134.34%.
  • Per our database at Business Quant, MDxHealth's EBIT Margin surged by 3175800bps in 2023 and then crashed by -1533300bps in 2025.
  • MDxHealth's EBIT Margin (Quarter) stood at 123.27% in 2021, then surged by 47bps to 181.48% in 2022, then dropped by -10bps to 163.15% in 2023, then decreased by -12bps to 144.07% in 2024, then decreased by -3bps to 139.95% in 2025.
  • Its last three reported values are 139.95% in Q3 2025, 0.06% for Q2 2025, and 146.53% during Q1 2025.